avian
influenza
viru
aiv
import
pathogen
caus
respiratori
diseas
sever
econom
loss
poultri
farm
seriou
menac
human
health
subtyp
low
pathogen
avian
influenza
viru
lpaiv
first
discov
unit
state
appear
china
wide
preval
worldwid
subtyp
still
import
aiv
infect
subtyp
aiv
result
symptom
like
respiratori
diseas
decreas
egg
product
poultri
may
promot
bacteri
infect
lead
high
mortal
moreov
aiv
directli
infect
human
mammal
studi
report
viru
could
gene
donor
subtyp
aiv
like
recent
year
aiv
play
increasingli
import
role
product
new
influenza
virus
subtyp
aiv
wide
spread
china
sinc
subtyp
aiv
infect
human
jiangxi
provinc
well
subtyp
current
preval
poultri
industri
china
addit
sequenc
analysi
indic
intern
gene
mainli
deriv
subtyp
aiv
highlight
role
influenza
viru
ecosystem
prevent
avian
influenza
china
mainli
vaccin
inactiv
vaccin
howev
inactiv
vaccin
abl
achiev
desir
protect
effect
possibl
reason
could
low
immun
frequenc
unreason
immun
procedur
clinic
practic
antigen
variat
epidem
strain
lead
unsatisfactori
vaccin
protect
therefor
increas
cellular
mucos
immun
might
crucial
allevi
limit
inactiv
vaccin
immun
viru
mainli
transmit
respiratori
mucos
pathway
play
import
role
control
avian
influenza
infect
howev
convent
vaccin
face
difficulti
induc
mucos
immun
mucos
rout
thu
oral
vaccin
simultan
induc
mucos
immun
system
immun
might
viabl
solut
prevent
control
viru
foodgrad
thu
safe
bacteria
l
lacti
wide
use
oral
vaccin
carrier
probiot
l
lacti
natur
present
intestin
human
anim
provid
certain
nutrient
bodi
inhibit
reproduct
harm
bacteria
maintain
balanc
gastrointestin
flora
thu
improv
function
gastrointestin
tract
furthermor
l
lacti
also
stimul
immun
cell
enhanc
mucos
immun
machineri
natur
activ
immun
respons
mani
studi
shown
recombin
express
viral
antigen
l
lacti
induc
effect
antivir
immun
respons
express
exogen
sever
acut
respiratori
syndrom
sar
viru
structur
protein
footandmouth
diseas
viru
rotaviru
protein
porcin
circoviru
type
nucleocapsid
protein
infecti
bursal
diseas
viru
protein
avian
hepat
e
viru
vivo
experi
shown
foreign
protein
capabl
induc
specif
mucos
humor
cellular
immun
respons
enhanc
abil
anim
resist
pathogen
infect
therefor
would
advantag
use
l
lacti
carrier
express
foreign
antigen
protein
viral
surfac
glycoprotein
hemagglutinin
ha
import
immunoprotect
antigen
viru
produc
specif
neutral
antibodi
differ
anim
model
hemagglutinin
absorb
cellular
receptor
like
sialic
acid
host
mediat
viral
adsorpt
transmembran
infect
ha
monom
cleav
form
wherein
globular
structur
form
rich
receptor
bind
site
strong
variabl
recogn
neutral
antibodi
stem
structur
anchor
viral
envelop
primari
function
fuse
viral
envelop
cell
membran
releas
nucleocapsid
virion
addit
sequenc
highli
conserv
especi
subtyp
therefor
vaccin
base
conserv
region
consid
aiv
section
rna
encod
matrix
protein
includ
protein
respons
mainten
highli
conserv
structur
protein
aiv
consist
amino
acid
residu
account
total
viral
protein
protein
involv
mani
aspect
viral
life
cycl
one
major
target
protein
host
cell
recognit
viral
infect
berthoud
et
al
use
vaccinia
vector
express
influenza
viru
gene
clinic
trial
result
show
vaccin
could
induc
strong
specif
lymphocyt
reaction
bodi
okuda
et
al
found
proteinbas
nucleic
acid
vaccin
protect
infect
homolog
influenza
viru
also
protect
infect
heterolog
influenza
viru
therefor
protein
potenti
candid
develop
crossprotect
vaccin
control
spread
subtyp
avian
influenza
viru
aiv
may
requir
develop
novel
type
vaccin
addit
inactiv
vaccin
oral
vaccin
typic
abl
activ
mucos
system
immun
unlik
inactiv
vaccin
studi
identifi
clinic
isol
subtyp
aiv
good
immunogen
gene
isol
infram
fusion
clone
construct
recombin
lactococcu
lacti
strain
express
fusion
protein
evalu
immunogen
recombin
l
lacti
strain
protect
effect
viru
challeng
follow
oral
immun
studi
aim
provid
complementari
approach
prevent
control
subtyp
aiv
anim
experi
approv
anim
protect
util
committe
shandong
agricultur
univers
permit
number
execut
accord
guid
anim
experi
ministri
scienc
technolog
beij
china
studi
involv
endang
protect
speci
viru
isol
two
commerci
strain
l
lacti
strain
preserv
laboratori
polyclon
antibodi
posit
sera
serum
crossreact
prepar
laboratori
l
lacti
cultur
gm
medium
broth
lactos
glucos
option
agar
monoclon
antichicken
antibodi
purchas
southern
biotech
san
diego
ca
usa
inactiv
vaccin
purchas
biotech
compani
weik
biotechnolog
china
prior
studi
first
assess
serum
crossreact
differ
strain
isol
laboratori
two
commerci
strain
serv
control
tabl
strain
recogn
mani
sera
select
vaccin
candid
strain
gene
strain
sequenc
infram
fusion
gene
synthes
codon
optim
l
lacti
genewiz
china
fusion
protein
encod
link
tenamino
acid
linker
gene
nco
xba
restrict
site
clone
vector
confirm
polymeras
chain
reaction
pcr
sequenc
tsingk
beij
recombin
plasmid
transform
e
coli
strain
expand
yield
primer
use
pcr
list
tabl
compet
l
lacti
strain
transform
recombin
plasmid
yield
l
lacti
strain
strain
transform
empti
plasmid
yield
l
lacti
strain
protein
express
induc
use
nisin
l
lacti
cell
harvest
centrifug
h
postnisin
induct
cultur
medium
concentr
use
centrifug
filter
devic
kda
collect
secret
protein
recombin
protein
identifi
western
blot
describ
previous
media
prepar
accord
nisincontrol
express
system
manual
lacti
strain
lacti
strain
primit
l
lacti
strain
cultur
gm
medium
allow
stand
h
cultur
medium
taken
everi
h
number
viabl
cell
medium
determin
use
plate
count
method
eighti
specificpathogenfre
spf
chicken
randomli
divid
four
group
chicken
per
group
chicken
first
second
group
oral
vaccin
cfuml
l
lacti
strain
respect
chicken
third
group
oral
vaccin
phosphatebuff
salin
pb
mlchicken
chicken
fourth
group
receiv
intramuscular
inject
inactiv
vaccin
mlchicken
chicken
receiv
boost
immun
week
later
group
intranas
challeng
aiv
studi
procedur
shown
figur
sera
collect
dpv
hi
antibodi
titer
serum
antibodi
detect
follow
previou
studi
siga
detect
perform
use
chicken
siga
elisa
kit
lengton
bioscienc
co
ltd
shanghai
china
accord
manufactur
protocol
intestin
tissu
serumspecif
igg
antibodi
level
measur
indirect
enzymelink
immunosorb
assay
elisa
method
accord
previous
report
method
intestin
mucos
cytokin
ifn
detect
realtim
pcr
realtim
pcr
perform
accord
method
describ
wang
et
al
experiment
primer
list
tabl
method
use
normal
data
percentag
lymphocyt
peripher
blood
measur
flow
cytometri
follow
method
describ
previous
publish
literatur
laboratori
seven
day
follow
challeng
five
randomlyselect
chicken
group
sacrif
lung
tissu
collect
viral
titer
lung
quantit
patholog
alveol
peribronchiolar
inflamm
lung
visual
hematoxylin
eosin
stain
chang
bodi
weight
chicken
follow
challeng
record
result
express
mean
standard
deviat
sd
analyz
use
spss
softwar
spss
incorpor
chicago
il
usa
group
differ
compar
student
ttest
pvalu
p
consid
statist
signific
consid
highli
statist
signific
gene
amplifi
pcr
product
clone
express
vector
verifi
univers
primer
figur
doubl
digest
figur
subsequ
recombin
blank
plasmid
separ
transform
compet
l
lacti
cell
upon
induct
nisin
h
novel
express
protein
band
correspond
kda
concentr
cultur
supernat
recombin
transform
visual
western
blot
analysi
figur
result
indic
express
recombin
fusion
protein
good
reactogen
specif
antibodi
moreov
predict
structur
partial
antigen
fusion
protein
homolog
model
use
swissmodel
display
rel
independ
structur
protein
figur
verifi
effect
recombin
plasmid
growth
l
lacti
measur
growth
curv
figur
result
show
recombin
plasmid
signific
effect
growth
l
lacti
differ
time
point
p
recombin
l
lacti
strain
use
oral
vaccin
immun
spf
chicken
hi
antibodi
level
induc
fusion
protein
quantit
sera
collect
chicken
dpv
hi
antibodi
titer
determin
figur
hi
antibodi
level
chicken
oral
vaccin
l
lacti
increas
compar
chicken
vaccin
l
lacti
pb
p
p
respect
howev
immun
inactiv
vaccin
induc
higher
hi
antibodi
level
recombin
l
lacti
oral
vaccin
normal
dose
rang
p
level
siga
intestin
mucosa
bronchoalveolar
lavag
fluid
balf
follow
vaccin
measur
use
chicken
siga
elisa
kit
level
serum
igg
measur
indirect
elisa
siga
content
group
show
continu
upward
trend
dpv
intestin
siga
level
l
lactisvaccin
group
reach
higher
pbsvaccin
group
higher
l
lactisvaccin
group
p
p
respect
siga
level
l
lactisvaccin
group
also
significantli
higher
compar
inactiv
vaccin
group
p
figur
antigenspecif
siga
titer
balf
show
similar
trend
antigenspecif
serum
igg
titer
titer
l
lactisvaccin
group
significantli
higher
pbsvaccin
l
lactisvaccin
group
p
p
respect
howev
siga
serum
igg
titer
differ
significantli
l
lactisvaccin
group
inactiv
vaccin
group
p
p
respect
figur
c
dpv
level
interleukin
il
interferon
ifn
l
lactisvaccin
group
significantli
higher
pbsvaccin
group
p
p
respect
signific
differ
level
among
group
p
dpv
level
l
lactisvaccin
group
higher
pbsvaccin
group
p
howev
level
cytokin
differ
significantli
l
lactisvaccin
group
l
lactisvaccin
group
p
week
l
lactisvaccin
group
show
significantli
increas
level
three
cytokin
compar
pbsvaccin
inactiv
vaccin
group
p
figur
percentag
cell
directli
reflect
immun
function
anim
result
statist
analysi
lymphocyt
peripher
blood
shown
tabl
respect
compar
pb
group
level
group
significantli
differ
dpv
p
similarli
level
lacti
lacti
group
significantli
higher
two
group
p
inactiv
vaccin
group
significantli
higher
pb
group
p
order
evalu
protect
effect
recombin
lacti
strain
subtyp
aiv
bodi
weight
chang
lung
tissu
viru
titer
group
statist
analyz
challeng
experi
result
indic
bodi
weight
pb
group
lacti
group
show
downward
trend
viru
infect
extrem
significantli
lower
two
group
p
p
howev
signific
differ
lacti
group
inactiv
vaccin
group
p
figur
addit
detect
viru
titer
lung
group
day
infect
result
show
lacti
group
significantli
higher
inactiv
vaccin
group
p
compar
pb
lacti
group
lung
viru
titer
significantli
reduc
p
p
figur
order
confirm
protect
effect
oral
vaccin
pulmonari
section
group
prepar
evalu
patholog
chang
figur
result
show
obviou
lesion
lacti
group
inactiv
vaccin
group
group
differ
degre
lesion
homogen
redstain
protein
exud
larg
number
inflammatori
cell
lung
chamber
collaps
pulmonari
epitheli
cell
detach
prevent
control
avian
influenza
seriou
problem
worldwid
current
common
strategi
inocul
inactiv
vaccin
almost
poultri
china
howev
aiv
still
preval
china
although
vaccin
strain
constantli
updat
like
difficult
effect
control
spread
aiv
use
inactiv
vaccin
mainli
induc
humor
immun
thu
promot
mucos
immun
respons
may
contribut
control
viru
studi
construct
recombin
l
lacti
strain
secret
fusion
protein
viru
evalu
immun
index
show
induc
substanti
mucos
immun
good
protect
effect
viru
challeng
mucosa
first
physic
barrier
entri
pathogen
microorgan
anim
mucos
immun
primari
protect
microbi
infect
initi
enter
bodi
respiratori
mucosa
therefor
mucos
immun
must
import
effect
way
fight
viru
siga
immunoglobulin
import
compon
mucos
immun
form
protect
barrier
adhes
epitheli
cell
also
adher
newli
synthes
viral
protein
infect
cell
interfer
virion
assembl
protect
potenti
siga
antibodi
appear
result
polymer
natur
result
higher
affin
antibodi
aiv
prevent
infect
block
adhes
epitheli
cell
result
indic
construct
recombin
l
lacti
could
secret
express
fusion
protein
induc
substanti
product
siga
viru
challeng
result
show
recombin
l
lactisimmun
chicken
induc
immun
protect
consist
result
inactiv
vaccin
significantli
inhibit
chicken
weight
loss
histopatholog
damag
inflammatori
respons
fact
inactiv
vaccin
induc
higher
serum
antibodi
may
due
higher
antigen
content
effect
vaccin
adjuv
recombin
l
lacti
oral
vaccin
induc
higher
mucos
antibodi
thu
recombin
l
lacti
use
oral
vaccin
compens
function
defici
inactiv
vaccin
moreov
probiot
effect
l
lacti
promot
cellular
respons
also
detect
upregul
cytokin
promot
activ
prolifer
intestin
mucos
lymphoid
b
cell
induc
secret
specif
siga
particip
transmiss
inform
play
import
role
biolog
process
organ
describ
fusion
protein
express
l
lacti
protein
one
abund
protein
virion
rel
conserv
may
affect
viral
replic
earli
viral
infect
mediat
germin
assembl
progeni
virion
hemagglutinin
major
target
neutral
antibodi
agglutin
subunit
vaccin
base
conserv
sequenc
induc
wide
rang
crossreact
antibodi
respons
provid
protect
influenza
viru
relat
studi
shown
express
protein
e
coli
use
candid
protein
develop
novel
influenza
vaccin
previou
studi
clarifi
immun
effect
protein
product
specif
serum
antibodi
virus
mice
immun
purifi
antigen
chitosan
show
strong
immun
respons
resist
infect
multipl
subtyp
influenza
viru
studi
also
select
protein
due
rel
small
molecular
mass
fuse
anoth
protect
antigen
immunogen
recombin
l
lacti
strain
express
fusion
protein
similar
previouslyreport
lactobacillu
strain
express
protein
previou
report
document
immunoprotect
effect
protein
instanc
lactobacillu
plantarum
express
could
elicit
antiaiv
humor
immun
specif
cellmedi
respons
moreov
fusion
protein
antigen
elicit
broader
potent
viral
inhibit
either
fusion
partner
alon
anoth
previou
studi
show
l
plantarum
display
fusion
protein
bacteri
surfac
elicit
protect
immun
respons
viral
infect
although
contain
conserv
neutral
epitop
low
immunogen
requir
fuse
protein
highmolecular
weight
carrier
gener
immun
respons
protein
use
studi
highli
conserv
structur
protein
use
potenti
candid
design
crossprotect
vaccin
addit
gene
use
studi
deriv
clinic
isol
select
base
recognit
multipl
sera
moreov
antigen
structur
separ
linker
sequenc
theoret
allow
play
distinct
antigen
role
addit
ad
secretori
peptid
gene
express
vector
result
secret
fusion
protein
l
lacti
therefor
design
sever
improv
previou
studi
signific
advantag
oral
vaccin
abil
trigger
mucos
system
immun
respons
foreign
microbi
infect
mucos
immun
lead
stronger
mucos
immun
respons
immun
rout
import
respiratori
tract
pathogen
like
influenza
viru
l
lacti
probiot
ideal
oral
live
vaccin
antigen
deliveri
vector
mani
advantag
tradit
vaccin
stimul
local
immun
respons
intestin
exert
probiot
effect
anim
bodi
thu
improv
mucos
immun
resist
colon
certain
pathogen
bacteria
method
simpl
oper
complianc
anim
welfar
regul
suitabl
largescal
anim
vaccin
studi
recombin
l
lacti
strain
express
fusion
protein
success
construct
oral
vaccin
strain
could
significantli
reduc
infect
chicken
activ
mucos
immun
find
provid
feasibl
method
mucos
prevent
control
subtyp
aiv
combin
applic
oral
vaccin
inactiv
vaccin
may
achiev
superior
efficaci
dataset
gener
studi
includ
articlesupplementari
materi
anim
studi
review
approv
anim
protect
util
committe
shandong
agricultur
univers
permit
number
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
